Terumo’s Post

Which Countries Lead the Rankings and How Do They Compare? India leads with a score of 5.8, followed by #China at 5.3 and #Japan at 5.2. #Brazil and the #UK hold strong positions at 5.1 and 4.8 respectively, alongside #SouthAfrica. #Germany, #Mexico, and #SaudiArabia are close behind, reflecting a diverse and competitive landscape in global rankings. Key Market Players: Sysmex Corporation, Danaher Corporation, Siemens, Abbott,Erba Mannheim,Wohlfahrtsstiftung der F. Hoffmann-La Roche AG, Nihon Kohden America, EKF DIAGNOSTICS HOLDINGS PLC, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Cardinal Health Want To Know More:https://lnkd.in/dNHqaMR2 #GlobalRankings #CountryScores #TopCountries #EconomicRanking #InternationalComparison #GlobalLeadership #CountryPerformance #Rankings2024

Come to Japan! Japan is an excellent market for advanced therapies, offering unique advantages. Its regulatory environment allows for faster approvals compared to the US and Europe. Japan's aging population and strong healthcare system create a high demand for new treatments. The US market is large but challenging due to complex reimbursement and long FDA approval times. Europe offers diverse opportunities but is fragmented with different regulations across countries. In contrast, Japan's streamlined process ensures quicker access to the market. Japan supports innovation in life sciences with government incentives and high R&D investment. Its research institutions and hospitals provide a solid base for clinical trials and post-market studies. This environment makes Japan an attractive market for advanced therapies. We are in Japan and always positive to exploratory dialogue. #AdvancedTherapies #JapanMarket #RegulatoryAdvantages #HealthcareDemand #InnovationSupport #GlobalStrategy #LifeSciences

📣Online & onsite participation available! Nordic Health Summit Japan on April 25th 2024 🩺 Nordic Health Summit Japan is a partnering and investor conference that connects Nordic healthcare innovations and Japanese investors and the industry. We invite innovative Nordic companies to meet with the Japanese top pharmaceutical companies, financial investors and medical device companies eager to connect with the Nordics 🤝   Nordic startups joining from the following fields are particularly welcome: 🩺 HealthTech 🔬 MedTech 🦠 BioTech 🧬 Life Science   Results from last year:  +100 matchmakings conducted 💪 94% likely or very likely to join again 📬 80% likely or very likely gained new business opportunities 🚀 For this years edition, we already have major Japanese pharmaceutical companies and financial investors registered 🚀   Sign up now and gain a unique opportunity to connect to the 3rd largest healthcare market in the world! ✅https://lnkd.in/eksquEe2 Reasonable participation fees for Nordic companies at approx. 4000 SEK to join onsite in Tokyo (travel etc. not included) and approx. 2000 SEK to join online. Nordic Health Summit Japan is co-organized by Business Sweden, Business Finland, Business Iceland, Innovasjon Norge, Royal Danish Embassy Trade Council, and Nordic Innovation House - Tokyo. #NordicMade #NordicInnovation #Japan #MarketEntry #Matchmaking #Healthcare

💊 The 2024 pricing reform in Japan will improve patient access to innovative therapies 💊 Updates and new rules will go live this April, bringing the following changes: 🔷 Introducing a new “rapid launch” premium, awarded to products launched in Japan within 6 months of first approval in EU and the US.  🔷Improving evaluation for various launch premiums, covering the usefulness, marketability, paediatric and SAKIGAKE premium.  🔷Relaxing post-launch price revisions by expanding the price maintenance premium.  Over the years, Inbeeo has developed deep expertise on the pricing and access pathways in Japan. Our price simulation model incorporates Japan's different pricing methods to offer strategic insights and pricing solutions.   Want to know more? Reach out for a chat to discuss and explore how we can be your strategic partner in answering your questions on pricing and reimbursement in Japan! #MarketAccess #Japan #DrugPricing 

Webinar | Building Successful China Medtech Market Entry Strategies Medtech manufacturers are sometimes hesitant to explore the vast China market potential. Being the fourth-largest spender on medical devices globally, China's market should not be overlooked or underestimated. This session will share actionable insights from experienced international experts to describe how the market is realistic and achievable. international experts to describe how the market is realistic and achievable. Date: Wednesday, January 24, 2024 Time: 11am EST / 4pm GMT Speakers: Hamish King 高远 (Olex Nykytyuk) Key insights - Understand the market dynamics and recent trends for medtech registrations in China. - Learn about the pivotal role of regulatory and distributor partnerships in achieving success in the Chinese medtech market. - Gain valuable insights from seasoned experts on overcoming challenges and establishing successful collaborations to navigate this dynamic market effectively. - Understand minimum production steps to become “Made in China” product for purposes of competing in public tenders. - Explore market access channels and gain insights into pricing and marketing strategies. Please find the link to register in the comments below. #medtech #Chinamarket #regulatory #registration

Webinar: Developing your China medtech market entry strategy Western medtech firms can be hesitant to explore the China market. But, as the fourth-largest spender on medical devices, China should certainly not be overlooked. This session, hosted by regulatory affairs consultancy Cisema, will present practical insights into how to succeed in the Chinese market. Cisema CEO Hamish King will be presenting, alongside our Shanghai-based medtech business development specialist Olex Nykytyuk. They will cover: - Market dynamics and trends in Chinese medtech registrations - The pivotal role of regulatory and distributor partnerships - How to overcome challenges and establish successful collaborations - The minimum production steps to become a “Made in China” product to compete in public tenders - Market access channels and pricing strategies Hope you can join us - sign up here: https://lnkd.in/eq_8M6ah

Hi #DIA2024 attendees, did you saw the video wall in front of the entrance to the exhibit hall? Visit EPS booth #1627 for more information about conducting clinical trials in Japan. #DIA2024 #DIAAnnualMeeting #outsourcing #clinicaltrials #OutsourcingClinicalTrials #APAC #JAPANCRO

Hi #DIA2024 attendees, did you saw the video wall in front of the entrance to the exhibit hall? Visit EPS booth #1627 for more information about conducting clinical trials in Japan. #DIA2024 #DIAAnnualMeeting #outsourcing #clinicaltrials #OutsourcingClinicalTrials #APAC #JAPANCRO

In today's competitive landscape, staying informed is key to success. Our newly released report, "The IVD Market in South Korea, 2024," is your definitive guide to understanding and capitalizing on the opportunities in South Korea's dynamic IVD market. Check out a data highlight from this report below! Backed by extensive primary and secondary research, this report equips you with valuable data to make informed decisions. Dive into the report here: https://hubs.la/Q02ptHdK0

For those interested in the evolving Japan pharma market, tune in to hear our expert Joeri De Haes!